Abstract
Late-stage melanoma is associated with high morbidity and mortality. Classic treatment methods relied on cytotoxic chemotherapy, which is limited by low response rates and significant adverse effects. Recent advances in immunogenetics have led to the advent of important new systemic treatments. This article reviews the latest therapy options for advanced melanoma.
| Original language | English |
|---|---|
| Pages (from-to) | 36-40 |
| Number of pages | 5 |
| Journal | Journal of Clinical and Aesthetic Dermatology |
| Volume | 9 |
| Issue number | 10 |
| State | Published - Oct 2016 |